Association for Accessible Medicines
USTRNonrulemakingUSTR-2018-0034

Request for Comments on Negotiating Objectives for a U.S.-Japan Trade Agreement

RIN
Last modified
Dec 26, 2018
Comment window
closed 2801d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Nov 27, 2018 and Nov 27, 2018. 111 other organizations filed here. The comment window closed 2801d ago.

What Association for Accessible Medicines filed (1)

Nov 27, 2018· Comment from Rachel Sher, Association for Accessible Medicines - Intent to Testify· USTR-2018-0034-0119

AAM requests the opportunity to provide testimony at the December 10, 2018, hearing. Depending on the particular date and time allocated to AAM, the witness will be: Jeffrey K. Francer Senior Vice President & General Counsel Association for Accessible Medicines 601 New Jersey Ave. NW, Suite 850 Washington, DC 20001 202-249-7100 or Rachel Sher Deputy General Counsel Association for Accessible Medicines 601 New Jersey Ave. NW, Suite 850 Washington, DC 20001 202-249-7100 AAMs testimony will address the issues covered in its written submission.

Abstract

No abstract recorded.

View on regulations.gov →